share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

SEC announcement ·  Feb 6 08:34
Summary by Futu AI
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a result, the total value of the shares after the action remains unknown.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a result, the total value of the shares after the action remains unknown.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.